Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Suiza
Tratamiento y acceso
- Tratamientos ofrecidosesketamine (Spravato)
- Vía de accesoCubierto por un programa nacional
- Coste y cobertura (estado en el registro)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
- ReembolsoBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 Cómo funciona el reembolso en Europa →
- Teléfono+41 21 314 31 11
- Sitio webhttps://www.chuv.ch/fr/psychiatrie/dp-home
Registros relacionados
Estos registros pertenecen a la misma organización. Se listan por separado porque cada uno es un programa o una ubicación distinta.
- Otro programa en esta clínicaMarie-Thérèse Clerc (CHUV Psychiatrie) — pat_program
Sobre este proveedor
The Centre Hospitalier Universitaire Vaudois (CHUV) is one of Switzerland's five university hospitals. Psychiatric care is provided by its Department of Psychiatry, headquartered at the Cery hospital site in Prilly near Lausanne, with additional inpatient facilities in Prangins and at the Centre de psychiatrie du Nord vaudois, and outpatient consultations for children, adults and older adults across canton Vaud. Specialised depression care is reached through the department's consultation network, usually on referral from a treating physician or psychiatrist.
Preguntas frecuentes
How do I access esketamine (Spravato) treatment at a university hospital?
Access runs through a psychiatrist. Your treating psychiatrist assesses whether you meet the Swiss criteria for treatment-resistant depression and refers you to the appropriate specialised consultation.
Is the treatment covered by health insurance?
Spravato is reimbursed by Swiss mandatory health insurance for treatment-resistant depression within the official criteria; the insurer must issue a cost approval (garantie de prise en charge) before the first dose.
Verificación
- Licencia / registroBAG SL Limitatio
- Fuentehttps://www.bag.admin.ch/dam/de/sd-web/uo93E02fcJBh/Liste%20der%20Zentren%20gem%C3%A4ss%20der%20Limitierung%20von%20Spravato_20251001.pdf
- Última verificación